狼人治疗公司
US ˙ NasdaqGS ˙ US95075A1079

介绍

本页面提供了有关 Sherman Michael A. 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Sherman Michael A.已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:CMRX / Chimerix, Inc. Chief Executive Officer, Director 0
US:HOWL / Werewolf Therapeutics, Inc. Director 23,200
Director 0
US:ECYT / Endocyte, Inc. President and CEO, Director 0
US:MJN / Mead Johnson Nutrition Co. Director 0
如何解读这些图表

以下图表显示了在Sherman Michael A.进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

HOWL / Werewolf Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 HOWL / Werewolf Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

HOWL / Werewolf Therapeutics, Inc. Insider Trades
HOWL / Werewolf Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 HOWL / Werewolf Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

HOWL / Werewolf Therapeutics, Inc. Insider Trades
内幕交易历史

该表格显示了由 Sherman Michael A. 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-04-21 2025-04-21 4 CMRX CHIMERIX INC
Common Stock
D - Sale to Issuer -233,413 0 -100.00 8.55 -1,995,681
2025-04-21 2025-04-21 4 CMRX CHIMERIX INC
Common Stock
D - Sale to Issuer -102,995 0 -100.00 8.55 -880,607
2025-04-21 2025-04-21 4 CMRX CHIMERIX INC
Common Stock
D - Sale to Issuer -87,000 0 -100.00 8.55 -743,850
2023-05-16 2023-05-12 4 CMRX CHIMERIX INC
Common Stock
P - Purchase 75,015 87,000 625.91 1.12 84,122 97,562
2023-05-16 2023-05-12 4 CMRX CHIMERIX INC
Common Stock
P - Purchase 11,985 11,985 1.13 13,530 13,530
2023-01-19 2023-01-17 4 CMRX CHIMERIX INC
Common Stock
A - Award 92,950 222,995 71.48
2022-07-27 2022-07-25 4/A CMRX CHIMERIX INC
Common Stock
M - Exercise 100,000 125,364 394.26 2.09 209,000 262,011
2022-07-26 2022-07-25 4 CMRX CHIMERIX INC
Common Stock
M - Exercise 100,000 125,364 394.26 2.09 209,000 262,011
2022-01-20 2022-01-18 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 875,000 875,000
2021-05-28 2021-05-27 4 HOWL Werewolf Therapeutics, Inc.
Stock Option (right to buy)
A - Award 23,200 23,200
2021-01-26 2021-01-22 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 700,000 700,000
2020-12-02 2020-12-02 4 BSTC BIOSPECIFICS TECHNOLOGIES CORP
Stock Option (Right to Buy)
D - Sale to Issuer -6,000 0 -100.00 32.87 -197,220
2020-12-02 2020-12-02 4 BSTC BIOSPECIFICS TECHNOLOGIES CORP
Common Stock, $0.001 par value
D - Sale to Issuer -2,018 0 -100.00
2020-05-04 2020-05-01 4 BSTC BIOSPECIFICS TECHNOLOGIES CORP
Stock Option (Right to Buy)
A - Award 6,000 6,000
2020-04-15 2020-04-13 4 BSTC BIOSPECIFICS TECHNOLOGIES CORP
Common Stock, $0.001 par value
A - Award 2,018 2,018
2020-03-16 2020-03-12 4 CMRX CHIMERIX INC
Common Stock
P - Purchase 72,995 102,995 243.32 1.45 105,653 149,075
2020-01-23 2020-01-21 4 CMRX CHIMERIX INC
Stock Option (Right to Buy)
A - Award 632,500 632,500
2019-05-20 2019-05-20 4 CMRX CHIMERIX INC
Common Stock
P - Purchase 30,000 30,000 3.48 104,316 104,316
2019-04-09 3 CMRX CHIMERIX INC
No securities are beneficially owned
0
2019-04-09 2019-04-08 4 CMRX CHIMERIX INC
Employee Stock Option (Right to Buy)
A - Award 1,250,000 1,250,000
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -225,000 0 -100.00 20.99 -4,722,750
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -187,500 0 -100.00 21.84 -4,095,000
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -60,000 0 -100.00 20.32 -1,219,200
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -86,248 0 -100.00 20.82 -1,795,683
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -86,247 0 -100.00 18.90 -1,630,068
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -36,000 0 -100.00 12.89 -464,040
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -58,719 0 -100.00 14.14 -830,287
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -74,998 0 -100.00 20.45 -1,533,709
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
D - Sale to Issuer -20,800 0 -100.00 14.95 -310,960
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Common Stock
D - Sale to Issuer -37,500 0 -100.00 24.00 -900,000
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Common Stock
D - Sale to Issuer -62,500 0 -100.00 24.00 -1,500,000
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Common Stock
D - Sale to Issuer -23,438 0 -100.00 24.00 -562,512
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Common Stock
D - Sale to Issuer -5,000 0 -100.00 24.00 -120,000
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Common Stock
D - Sale to Issuer -7,188 0 -100.00 24.00 -172,512
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Common Stock
D - Sale to Issuer -19,919 0 -100.00 24.00 -478,056
2018-12-21 2018-12-21 4 ECYT ENDOCYTE INC
Common Stock
D - Sale to Issuer -243,739 0 -100.00 24.00 -5,849,736
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock option (right to buy)
M - Exercise -2 86,248 0.00
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock option (right to buy)
M - Exercise -3 86,247 0.00
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock option (right to buy)
M - Exercise -9,000 36,000 -20.00
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock option (right to buy)
M - Exercise -11,281 58,719 -16.12
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock option (right to buy)
M - Exercise -25,002 74,998 -25.00
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -39,200 20,800 -65.33
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -15,706 0 -100.00
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock option (right to buy)
M - Exercise -10,035 0 -100.00
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -5,330 0 -100.00
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
G - Gift -84,112 379,365 -18.15
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 2 463,477 0.00 3.18 6 1,473,857
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 3 463,475 0.00 5.10 15 2,363,722
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 9,000 463,472 1.98 11.11 99,990 5,149,174
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 11,281 454,472 2.55 9.86 111,231 4,481,094
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 25,002 443,191 5.98 3.55 88,757 1,573,328
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 39,200 418,189 10.34 9.05 354,760 3,784,610
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 15,706 378,989 4.32 3.82 59,997 1,447,738
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 10,035 363,283 2.84 2.54 25,489 922,739
2018-12-19 2018-12-17 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 5,330 353,248 1.53 2.54 13,538 897,250
2018-10-09 2018-10-05 4 ECYT ENDOCYTE INC
Common Stock
S - Sale X -28,146 347,918 -7.48 15.55 -437,752 5,411,134
2018-02-08 2018-02-08 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
A - Award 225,000 225,000
2018-02-08 2018-02-08 4 ECYT ENDOCYTE INC
Common Stock
A - Award 37,500 376,064 11.08
2018-02-06 2018-02-02 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -5,453 0 -100.00
2018-02-06 2018-02-02 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 5,453 338,564 1.64 3.06 16,686 1,036,006
2017-10-06 2017-10-04 4 ECYT ENDOCYTE INC
Common Stock
A - Award 125,000 333,111 60.06
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Restricted Stock Units
D - Sale to Issuer -1,709 0 -100.00 90.00 -153,810
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -4,051 0 -100.00 90.00 -364,590
2017-06-02 2017-05-31 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -44,285 0 -100.00
2017-06-02 2017-05-31 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 44,285 208,111 27.03 2.10 92,998 437,033
2017-03-02 2017-03-01 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -2,373 0 -100.00
2017-03-02 2017-03-01 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 2,373 4,051 141.42
2017-03-02 2017-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1,709 1,709
2017-02-07 2017-02-06 4 ECYT ENDOCYTE INC
Common Stock
F - Taxes -692 163,826 -0.42 2.18 -1,509 357,141
2017-02-07 2017-02-04 4 ECYT ENDOCYTE INC
Common Stock
F - Taxes -3,092 164,518 -1.84 2.18 -6,741 358,649
2017-02-03 2017-02-02 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
A - Award 187,500 187,500
2017-02-03 2017-02-02 4 ECYT ENDOCYTE INC
Common Stock
A - Award 31,250 167,610 22.92
2016-06-20 2016-06-16 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
A - Award 60,000 60,000
2016-06-20 2016-06-16 4 ECYT ENDOCYTE INC
Common Stock
A - Award 10,000 136,360 7.91
2016-03-01 2016-02-29 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise 2,373 2,373
2016-03-01 2016-02-26 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -1,678 0 -100.00
2016-03-01 2016-02-26 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1,678 1,678
2016-02-08 2016-02-06 4 ECYT ENDOCYTE INC
Common Stock
F - Taxes -694 124,972 -0.55 3.02 -2,096 377,415
2016-02-08 2016-02-04 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
A - Award 86,250 86,250
2016-02-08 2016-02-04 4 ECYT ENDOCYTE INC
Common Stock
F - Taxes -1,771 125,666 -1.39 3.18 -5,632 399,618
2016-02-08 2016-02-04 4 ECYT ENDOCYTE INC
Common Stock
A - Award 14,375 127,437 12.71
2015-02-27 2015-02-26 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1,678 1,678
2015-02-06 2015-02-06 4 ECYT ENDOCYTE INC
Common Stock
F - Taxes -693 110,909 -0.62 5.14 -3,562 570,072
2015-02-06 2015-02-04 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
A - Award 86,250 86,250
2015-02-06 2015-02-04 4 ECYT ENDOCYTE INC
Common Stock
A - Award 14,375 111,602 14.78
2014-11-04 2014-10-31 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -436 10,035 -4.16
2014-11-04 2014-10-31 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -1,402 5,330 -20.83
2014-11-04 2014-10-31 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -5,018 5,453 -47.92
2014-11-04 2014-10-31 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
M - Exercise -8,071 44,285 -15.42
2014-11-04 2014-10-31 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 1,838 96,391 1.94 2.54 4,669 244,833
2014-11-04 2014-10-31 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 5,018 94,553 5.60 3.06 15,355 289,332
2014-11-04 2014-10-31 4 ECYT ENDOCYTE INC
Common Stock
M - Exercise 8,071 89,535 9.91 2.10 16,949 188,024
2014-02-10 2014-02-06 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
A - Award 45,000 45,000
2014-02-10 2014-02-06 4 ECYT ENDOCYTE INC
Common Stock
A - Award 7,500 80,798 10.23
2013-02-21 2013-02-19 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
A - Award 70,000 70,000
2012-03-02 2012-02-29 4 ECYT ENDOCYTE INC
Stock Option (right to buy)
A - Award 100,000 100,000
2012-02-15 2011-05-13 5 ECYT ENDOCYTE INC
Common Stock
G - Gift -19,919 73,298 -21.37
2011-02-04 3 ECYT ENDOCYTE INC
Common Stock
52,356
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)